Report cover image

Daptomycin Market

Publisher Evolve Business Intelligence
Published Apr 14, 2025
SKU # EVBI19932365

Description

The global Daptomycin market size was valued at $XX million in 2020 and is projected to reach $XX million by 2028, growing at a CAGR of 4.2% from 2021 to 2028. This growth is driven by several macro and microeconomic factors, including the increasing prevalence of skin infections.

The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.

Segments covered

By Strength (350 mg, 500 mg)
By Age Group (Adult, Pediatric)
By Indication (Complicated Skin Structure infections, Bacteremia, Others)

Key players

Teva Pharmaceutical Industries Ltd.
Merck &co.
Cipla
Pfizer
BE Pharmaceuticals
Reddy’s Laboratories
Mylan
Fresenius Kabi
Nichi-Iko Pharmaceutical
Civica Rx

Table of Contents

Chapter 1. Executive Summary
Chapter 2. Scope of The Study
2.1. Market Definition
2.2. Scope of The Study
2.2.1. Objectives of Report
Chapter 3. Evolve BI Methodology
Chapter 4. Market Insights and Trends
4.1. Supply/ Value Chain Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitutes
4.2.5. Industry Rivalry
4.3. Impact of COVID-19 on Daptomycin Market
4.3.1. Impact on Market Size
4.3.2. End User Trend, Preferences and Budget Impact
4.3.3. Regulatory Framework/Government Policies
4.3.4. Key Players Strategy to Tackle Negative Impact
4.3.5. Opportunity Window
Chapter 5. Market Dynamics
5.1. Introduction
5.2. DRO Analysis
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Opportunities
Chapter 6. Global Daptomycin Market, By Strength
6.1. Introduction
6.2. 350 mg
6.3. 500 mg
Chapter 7. Global Daptomycin Market, By Component
7.1. Introduction
7.2. Adult
7.3. Pediatric
Chapter 8. Global Daptomycin Market, By Vehicle Type
8.1. Introduction
8.2. Complicated Skin Structure infections
8.3. Bacteremia
8.4. Others
Chapter 9. Global Daptomycin Market, By Region
9.1. Introduction
9.2. North America
9.2.1. Introduction
9.2.2. Driving Factors, Opportunity Analyzed and Key Trends
9.2.3. Market Size and Forecast, By Country, 2020 - 2028
9.2.4. Market Size and Forecast, By Strength, 2020 - 2028
9.2.5. Market Size and Forecast, By Component, 2020 – 2028
9.2.6. Market Size and Forecast, By Vehicle Type, 2020 – 2028
9.2.7. US
9.2.7.1. Introduction
9.2.7.2. Driving Factors, Opportunity Analyzed and Key Trends
9.2.7.3. Market Size and Forecast, By Strength, 2020 - 2028
9.2.7.4. Market Size and Forecast, By Component, 2020 – 2028
9.2.7.5. Market Size and Forecast, By Vehicle Type, 2020 - 2028
9.2.8. Canada
9.2.8.1. Introduction
9.2.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.2.8.4. Market Size and Forecast, By Strength, 2020 - 2028
9.2.8.5. Market Size and Forecast, By Component, 2020 – 2028
9.2.8.6. Market Size and Forecast, By Vehicle Type, 2020 - 2028
9.3. Europe
9.3.1. Introduction
9.3.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.3. Market Size and Forecast, By Country, 2020 - 2028
9.3.4. Market Size and Forecast, By Strength, 2020 - 2028
9.3.5. Market Size and Forecast, By Component, 2020 – 2028
9.3.6. Market Size and Forecast, By Vehicle Type, 2020 – 2028
9.3.7. Germany
9.3.7.1. Introduction
9.3.7.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.7.3. Market Size and Forecast, By Strength, 2020 - 2028
9.3.7.4. Market Size and Forecast, By Component, 2020 – 2028
9.3.7.5. Market Size and Forecast, By Vehicle Type, 2020 - 2028
9.3.8. France
9.3.8.1. Introduction
9.3.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.8.3. Market Size and Forecast, By Strength, 2020 - 2028
9.3.8.4. Market Size and Forecast, By Component, 2020 – 2028
9.3.8.5. Market Size and Forecast, By Vehicle Type, 2020 - 2028
9.3.9. UK
9.3.9.1. Introduction
9.3.9.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.9.3. Market Size and Forecast, By Strength, 2020 - 2028
9.3.9.4. Market Size and Forecast, By Component, 2020 – 2028
9.3.9.5. Market Size and Forecast, By Vehicle Type, 2020 - 2028
9.3.10. Italy
9.3.10.1. Introduction
9.3.10.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.10.3. Market Size and Forecast, By Strength, 2020 - 2028
9.3.10.4. Market Size and Forecast, By Component, 2020 – 2028
9.3.10.5. Market Size and Forecast, By Vehicle Type, 2020 - 2028
9.3.11. Rest of Europe
9.3.11.1. Introduction
9.3.11.2. Driving Factors, Opportunity Analyzed and Key Trends
9.3.11.3. Market Size and Forecast, By Strength, 2020 - 2028
9.3.11.4. Market Size and Forecast, By Component, 2020 – 2028
9.3.11.5. Market Size and Forecast, By Vehicle Type, 2020 - 2028
9.4. Asia-Pacific
9.4.1. Introduction
9.4.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.3. Market Size and Forecast, By Country, 2020 - 2028
9.4.4. Market Size and Forecast, By Strength, 2020 - 2028
9.4.5. Market Size and Forecast, By Component, 2020 – 2028
9.4.7. Market Size and Forecast, By Vehicle Type, 2020 - 2028
9.4.8. China
9.4.8.1. Introduction
9.4.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.8.3. Market Size and Forecast, By Strength, 2020 - 2028
9.4.8.4. Market Size and Forecast, By Component, 2020 – 2028
9.4.8.5. Market Size and Forecast, By Vehicle Type, 2020 - 2028
9.4.9. India
9.4.9.1. Introduction
9.4.9.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.9.3. Market Size and Forecast, By Strength, 2020 - 2028
9.4.9.4. Market Size and Forecast, By Component, 2020 – 2028
9.4.9.5. Market Size and Forecast, By Vehicle Type, 2020 - 2028
9.4.10. Japan
9.4.10.1. Introduction
9.4.10.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.10.3. Market Size and Forecast, By Strength, 2020 - 2028
9.4.10.4. Market Size and Forecast, By Component, 2020 – 2028
9.4.10.5. Market Size and Forecast, By Vehicle Type, 2020 - 2028
9.4.11. South Korea
9.4.11.1. Introduction
9.4.11.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.11.3. Market Size and Forecast, By Strength, 2020 - 2028
9.4.11.4. Market Size and Forecast, By Component, 2020 – 2028
9.4.11.5. Market Size and Forecast, By Vehicle Type, 2020 - 2028
9.4.12. Rest of Asia-Pacific
9.4.11.1. Introduction
9.4.12.2. Driving Factors, Opportunity Analyzed and Key Trends
9.4.12.3. Market Size and Forecast, By Strength, 2020 - 2028
9.4.12.4. Market Size and Forecast, By Component, 2020 – 2028
9.4.12.5. Market Size and Forecast, By Vehicle Type, 2020 - 2028
9.5. Rest of The World (RoW)
9.5.1. Introduction
9.5.2. Driving Factors, Opportunity Analyzed and Key Trends
9.5.3. Market Size and Forecast, By Strength, 2020 - 2028
9.5.4. Market Size and Forecast, By Component, 2020 – 2028
9.5.5. Market Size and Forecast, By Vehicle Type, 2020 - 2028
9.5.6. Market Size and Forecast, By Region, 2020 - 2028
9.5.7. South America
9.5.7.1. Introduction
9.5.7.2. Driving Factors, Opportunity Analyzed and Key Trends
9.5.7.3. Market Size and Forecast, By Strength, 2020 - 2028
9.5.7.4. Market Size and Forecast, By Component, 2020 – 2028
9.5.7.5. Market Size and Forecast, By Vehicle Type, 2020 - 2028
9.5.8. Middle East & Africa
9.5.8.1. Introduction
9.5.8.2. Driving Factors, Opportunity Analyzed and Key Trends
9.5.8.3. Market Size and Forecast, By Strength, 2020 - 2028
9.5.8.4. Market Size and Forecast, By Component, 2020 – 2028
9.5.8.5. Market Size and Forecast, By Vehicle Type, 2020 - 2028
Chapter 10. Competitive Landscape
10.1. Introduction
10.2. Vendor Share Analysis, 2020/Key Players Positioning 2020
Chapter 11. Company Profiles
11.1. Teva Pharmaceutical Industries Ltd.
11.1.1. Business Overview
11.1.2. Financial Analysis
11.1.3. Product Portfolio
11.1.4. Recent Development and Strategies Adopted
11.1.5. SWOT Analysis
11.2. Merck &co.
11.2.1. Business Overview
11.2.2. Financial Analysis
11.2.3. Product Portfolio
11.2.4. Recent Development and Strategies Adopted
11.2.5. SWOT Analysis
11.3. Cipla
11.3.1. Business Overview
11.3.2. Financial Analysis
11.3.3. Product Portfolio
11.3.4. Recent Development and Strategies Adopted
11.3.5. SWOT Analysis
11.4. Pfizer
11.4.1. Business Overview
11.4.2. Financial Analysis
11.4.3. Product Portfolio
11.4.4. Recent Development and Strategies Adopted
11.4.5. SWOT Analysis
11.5. BE Pharmaceuticals
11.5.1. Business Overview
11.5.2. Financial Analysis
11.5.3. Product Portfolio
11.5.4. Recent Development and Strategies Adopted
11.5.5. SWOT Analysis
11.6. Reddy’s Laboratories
11.6.1. Business Overview
11.6.2. Financial Analysis
11.6.3. Product Portfolio
11.6.4. Recent Development and Strategies Adopted
11.6.5. SWOT Analysis
11.7. Mylan
11.7.1. Business Overview
11.7.2. Financial Analysis
11.7.3. Product Portfolio
11.7.4. Recent Development and Strategies Adopted
11.7.5. SWOT Analysis
11.8. Fresenius Kabi
11.8.1. Business Overview
11.8.2. Financial Analysis
11.8.3. Product Portfolio
11.8.4. Recent Development and Strategies Adopted
11.8.5. SWOT Analysis
11.9. Nichi-Iko Pharmaceutical
11.9.1. Business Overview
11.9.2. Financial Analysis
11.9.3. Product Portfolio
11.9.4. Recent Development and Strategies Adopted
11.9.5. SWOT Analysis
11.10. Civica Rx
11.10.1. Business Overview
11.10.2. Financial Analysis
11.10.3. Product Portfolio
11.9.4. Recent Development and Strategies Adopted
11.9.5. SWOT Analysis
Chapter 12. Key Takeaways

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us